Investigational Site Number : 7240003

Madrid, Madrid, Comunidad de 28046

0 studies enrolling now · 5 studies all time

What they study most

Asthma, Breast Cancer Metastatic, Chronic Obstructive Pulmonary Disease, Pancreatic Carcinoma Metastatic, Squamous Cell Carcinoma of Head and Neck, Transplant Rejection

Studies at this site

• BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR) — Running, not enrolling
• Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors — Stopped early
• A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204) — Stopped early
• The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma — Completed
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation — Completed